Re-evaluation of progenitor thresholds and expectations for haematopoietic recovery based on an analysis of 810 autologous transplants: Implications for quality assurance

Br J Haematol. 2016 Nov;175(4):673-676. doi: 10.1111/bjh.14276. Epub 2016 Aug 9.

Abstract

Haematological engraftment was assessed in 804 autologous transplants. Neutrophil recovery occurred in over 99% within 14 d but platelet recovery was delayed beyond this time in 14·8%. Time to recovery was dependent on the progenitor cell dose infused. The minimum CD34+ cell threshold adopted in this study (2 × 106 /kg) was safe although recovery was faster with a dose >5 × 106 /kg. CD34+ cell doses of between 1 and 2 × 106 /kg were also acceptable if either the granulocyte-macrophage colony-forming cell dose exceeded 2 × 105 /kg or this dose was due to splitting a higher yield harvest. Prompt neutrophil recovery affords important quality assurance for laboratory processing.

Keywords: engraftment kinetics; progenitors; quality control; stem cell transplantation.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Blood Cell Count
  • Female
  • Graft Survival*
  • Hematopoiesis*
  • Hematopoietic Stem Cell Transplantation* / methods
  • Hematopoietic Stem Cell Transplantation* / standards
  • Hematopoietic Stem Cells*
  • Humans
  • Male
  • Middle Aged
  • Quality Assurance, Health Care
  • Time Factors
  • Transplantation Conditioning
  • Transplantation, Autologous
  • Treatment Outcome
  • Young Adult